China Center for Drug Evaluation / CDE

The China Center for Drug Evaluation / CDE appears in 130. 谁才是生物医药行业发展的核心驱动力？兼谈创新药产业链的角色分工 as the Chinese drug-review institution in the innovation-drug industry map. The source treats regulators as active industry actors because approval standards, clinical evidence expectations, and registration pathways shape what companies can fund and launch.

Connections

• Food and Drug Administration - U.S. counterpart named in the same source.
• Clinical Development Capability - trials and data packages are built for regulator review.
• Global Pharma Commercialization - global registration capacity as part of MNC capability.